Aurora Cannabis (ACB) financial statements
Aurora Cannabis reported revenue of 343M CAD in fiscal 2025, up 35.6% a year over 6 years.
Net income was 2M CAD and the operating margin 1.4%, against -173.5% in 2018.
Free cash flow was -3M CAD.
The diluted share count rose 18% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions (CAD).
Income statement
Fiscal years, in CAD, from Aurora Cannabis's 10-K filings with the SEC.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 55M CAD | 246M CAD | 269M CAD | 245M CAD | 221M CAD | 270M CAD | 343M CAD |
| Gross profit | 44M CAD | 142M CAD | -20M CAD | -22M CAD | 21M CAD | 132M CAD | 188M CAD |
| Research and development | 2M CAD | 15M CAD | 26M CAD | 11M CAD | 10M CAD | 4M CAD | 4M CAD |
| Selling, general and admin | 43M CAD | 159M CAD | 196M CAD | 175M CAD | 175M CAD | 144M CAD | 97M CAD |
| Operating income | -96M CAD | -318M CAD | -466M CAD | -283M CAD | -231M CAD | -45M CAD | 5M CAD |
| Interest expense | 12M CAD | 39M CAD | 76M CAD | 66M CAD | 72M CAD | 14M CAD | 8M CAD |
| Pre-tax income | 77M CAD | -331M CAD | -3.3B CAD | -700M CAD | -1.7B CAD | -58M CAD | 20M CAD |
| Income tax | 8M CAD | -30M CAD | -82M CAD | -6M CAD | -2M CAD | -554,000 CAD | 5M CAD |
| Net income | 72M CAD | -294M CAD | -3.3B CAD | -692M CAD | -1.7B CAD | -69M CAD | 2M CAD |
| EPS (diluted) | 1.50 CAD | -2.90 CAD | — | -41.00 CAD | -79.90 CAD | -1.52 CAD | 0.04 CAD |
| Diluted shares | 47M | 102M | 10M | 17M | 21M | 43M | 56M |
| Gross margin | 78.8% | 58.0% | -7.4% | -8.8% | 9.6% | 48.9% | 54.6% |
| Operating margin | -173.5% | -129.6% | -173.3% | -115.3% | -104.6% | -16.7% | 1.4% |
| Net margin | 130.3% | -119.5% | -1221.7% | -282.2% | -776.0% | -25.7% | 0.5% |
Balance sheet
Fiscal years, in CAD, from Aurora Cannabis's 10-K filings with the SEC.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash and short-term investments | 77M CAD | 173M CAD | 162M CAD | 421M CAD | 438M CAD | 140M CAD | 138M CAD |
| Receivables | 15M CAD | 103M CAD | 54M CAD | 56M CAD | 47M CAD | 45M CAD | 42M CAD |
| Inventory | 30M CAD | 111M CAD | 136M CAD | 117M CAD | 116M CAD | 144M CAD | 188M CAD |
| Total current assets | 220M CAD | 661M CAD | 418M CAD | 666M CAD | 745M CAD | 427M CAD | 478M CAD |
| Property, plant and equipment | 246M CAD | 766M CAD | 946M CAD | 606M CAD | 233M CAD | 264M CAD | 268M CAD |
| Goodwill | 761M CAD | 3.2B CAD | 928M CAD | 888M CAD | 0 CAD | 43M CAD | 44M CAD |
| Total assets | 1.9B CAD | 5.5B CAD | 2.8B CAD | 2.6B CAD | 1.1B CAD | 839M CAD | 853M CAD |
| Total current liabilities | 75M CAD | 436M CAD | 272M CAD | 116M CAD | 131M CAD | 125M CAD | 111M CAD |
| Long-term debt | 9M CAD | 127M CAD | 84M CAD | — | 0 CAD | 5M CAD | 40M CAD |
| Total liabilities | 334M CAD | 1.1B CAD | 657M CAD | 567M CAD | 422M CAD | 237M CAD | 244M CAD |
| Shareholders' equity | 1.5B CAD | 4.4B CAD | 2.1B CAD | 2.0B CAD | 662M CAD | 560M CAD | 567M CAD |
| Net debt | -65M CAD | -31M CAD | 35M CAD | -421M CAD | -438M CAD | -79M CAD | -95M CAD |
Cash flow
Fiscal years, in CAD, from Aurora Cannabis's 10-K filings with the SEC.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -82M CAD | -192M CAD | -342M CAD | -211M CAD | -110M CAD | -69M CAD | 16M CAD |
| Capital spending | 137M CAD | 414M CAD | — | 53M CAD | 32M CAD | 17M CAD | 19M CAD |
| Free cash flow | -219M CAD | -607M CAD | — | -264M CAD | -142M CAD | -85M CAD | -3M CAD |
| Stock-based compensation | 37M CAD | 107M CAD | 59M CAD | 20M CAD | 14M CAD | 13M CAD | 12M CAD |
| Net borrowing | 345M CAD | 584M CAD | -29M CAD | -118M CAD | 0 CAD | 12M CAD | 4M CAD |
| Free cash flow margin | -396.1% | -247.0% | — | -107.5% | -64.4% | -31.7% | -0.8% |
Questions
What was Aurora Cannabis's revenue in 2025?
343M CAD in fiscal 2025, from its 10-K filing.
How much free cash flow does Aurora Cannabis generate?
-3M CAD in fiscal 2025 (operating cash flow minus capital spending).
From Aurora Cannabis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.